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Abstract
Pregnancy anxiety is a potent predictor of adverse birth and infant outcomes. The goal of the
current study was to examine one potential mechanism whereby these effects may occur by testing
associations between pregnancy anxiety and maternal salivary cortisol on 4 occasions during
pregnancy in a sample of 448 women. Higher mean levels of pregnancy anxiety over the course of
pregnancy predicted steeper increases in cortisol trajectories compared to lower pregnancy
anxiety. Significant differences between cortisol trajectories emerged between 30 to 31 weeks of
gestation. Results remained significant when adjusted for state anxiety and perceived stress.
Neither changes in pregnancy anxiety over gestation, nor pregnancy anxiety specific to only a
particular time in pregnancy predicted cortisol. These findings provide support for one way in
which pregnancy anxiety may influence maternal physiology and contribute to a growing
literature on the complex biological pathways linking pregnancy anxiety to birth and infant
outcomes.
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Pregnancy anxiety is a highly specific type of maternal psychological distress defined as
anxiety concerning a mother's own health, the baby's health, and labor and delivery in the
context of a specific pregnancy (Dunkel Schetter, 2011). It is a potent and often more
consistent predictor of birth, infant and child outcomes than general forms of psychological
distress (Buss, Davis, Muftuler, Head, & Sandman, 2009; Dunkel Schetter & Glynn, 2011;
Kramer et al., 2009; Lobel et al., 2008; Roesch, Dunkel Schetter, Woo, & Hobel, 2004). For
example, pregnancy anxiety predicts preterm birth and gestational length (Kramer et al.,
2009; Mancuso, Dunkel Schetter, Rini, Roesch, & Hobel, 2004; Roesch et al., 2004), infant
mental and psychomotor development (Buitelaar, Huisink, Mulder, De Medina, & Visser,
2003; Davis & Sandman, 2010; Huisink, De Medina, Mulder, Visser, & Buitelaar, 2002),
child temperament (Blair, Glynn, Sandman, & Davis, 2011; Huisink et al., 2002; Sandman,
Davis, Buss, & Glynn, 2012), and brain morphology in young children (Buss et al., 2009).
However, little is known about the biological mechanisms that explain these effects.
Alterations in the maternal hypothalamic-pituitary-adrenal (HPA) axis and placenta are
hypothesized to be one explanatory mechanism (Seckl & Holmes, 2007; Van den Bergh,
Mulder, Mennes, & Glover, 2005). Strong evidence from animal models demonstrates that
maternal distress predicts increased fetal glucocorticoid exposure via synthesis and release
of maternal glucocorticoids (Maccari et al., 2003; Weinstock, 2005), but similar evidence in
humans linking pregnancy anxiety (or general maternal distress) to increased levels of
maternal cortisol during pregnancy is lacking. Thus, it is unclear if and how pregnancy
anxiety is associated with maternal cortisol during pregnancy. The purpose of this study was
to determine whether pregnancy anxiety is associated with cortisol levels and trajectories
over the course of pregnancy in an effort to better understand the broader processes linking
pregnancy anxiety to birth, infant and child outcomes.
During pregnancy, maternal cortisol increases 2 to 4 fold (Glynn, Dunkel Schetter, Chicz-
DeMet, Hobel & Sandman, 2007; Mastorakos & Ilias, 2003; Meulenberg & Hofman, 1990)
and passes through the placenta. However, the amount of maternal cortisol that crosses the
placental barrier is limited because its passage is regulated by the enzyme 11β-
hydroxysteroid dehydrogenase (11 β-HSD2: Benediktsson, Calder, Edwards & Seckl, 1997).
Still, maternal cortisol still accounts for approximately 30-40% of the variability in fetal
concentrations of cortisol (Gitau, Cameron, Fisk, & Glover, 1998; Gitau, Fisk, Teixeira,
Cameron, & Glover, 2001).
Maternal cortisol levels can affect birth and infant outcomes in multiple ways. For one,
cortisol stimulates the synthesis and release of placental corticotrophin-releasing hormone
(pCRH) (King, Smith & Nicholson, 2001). In humans, elevated cortisol early in pregnancy
predicts pCRH levels later in pregnancy (Sandman et al., 2006) and pCRH predicts preterm
birth (McLean & Smith, 2001). Maternal cortisol also acts directly on the fetus and its
developing nervous system (for reviews, see Davis & Sandman, 2006; Sandman, Davis &
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Glynn, 2012). For example, results of prospective studies have documented that relatively
high levels of prenatal maternal cortisol predict greater behavioral and physiological stress
reactivity in fetuses, infants and children (De Weerth, Van Hees, & Buitelaar, 2003; Davis,
Glynn, Waffarn, & Sandman, 2011), decreased cognitive ability in infants (Davis &
Sandman, 2010; Huizink, Robles de Medina, Mulder, Visser, & Buitelaar, 2003), increased
affective problems in young girls (Buss, Davis, Shahbaba, Pruessner, Head, & Sandman,
2012), and altered amygdala volumes in young girls (Buss et al., 2012).
In the literature, the association between pregnancy anxiety and maternal cortisol is
inconsistent at best. For example, a study of 603 women found that worries about
pregnancy-related complications were associated with high evening maternal cortisol late in
pregnancy (Obel et al., 2005), but with lower morning cortisol early in pregnancy. Several
other studies reported no associations between maternal cortisol and pregnancy anxiety
(Davis & Sandman, 2010; Goedhart et al., 2010; Harville, Savitz, Dole, Herring, & Thorp,
2009; Kivlighan, Dipietro, Costigan, & Laudenslager 2008; Pluess, Bolten, Pirke, &
Hellhammer, 2010; Sikkema et al., 2001). However, the majority of these studies assessed
maternal cortisol at only 1 or 2 time points during pregnancy, conducted only cross-sectional
analyses, or did not test changes in levels or trajectories of cortisol, thus limiting their ability
to detect potential associations.
The specific aim of the present study was to test predicted links between pregnancy anxiety
and both maternal cortisol levels at specific time points in pregnancy and cortisol trajectories
across pregnancy using multilevel modeling techniques. We hypothesized that higher levels
of pregnancy anxiety would be associated with higher levels of cortisol and steeper increases
in cortisol trajectories over pregnancy. We further hypothesized that pregnancy anxiety
would be an independent predictor of cortisol after adjusting for other commonly studied
measures of psychological distress (state anxiety and perceived stress).
Method
Study Design and Procedure
Study participants included women from a prospective longitudinal study assessing prenatal
psychosocial and behavioral factors in pregnancy, the Multi-Site Behavior in Pregnancy
Study (MSBIPS). Women were recruited in the Los Angeles area by research nurses at
prenatal clinics in two large urban medical centers. Data for this study were collected on 4
occasions over the course of pregnancy separated by six week intervals (T1: 18-20 weeks, M
= 19.29, SD = .80, T2: 24-26 weeks, M= 24.98, SD = .83, T3:30-32 weeks, M=30.98, SD = .
76, and T4: 36-38 weeks, M= 36.75, SD = .70). At each assessment, women completed
semi-structured interviews, questionnaires and provided one saliva sample for cortisol
assessment. All study protocols and procedures were approved by each institution's
Institutional Review Boards.
Participants
Inclusion criteria for the sample were 18 years of age, English ability, and singleton
intrauterine pregnancy. Exclusion criteria were tobacco, alcohol, or drug use during
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pregnancy, and medical conditions involving dysregulated neuroendocrine, cardiovascular,
hepatic or renal functioning.1 Sixty-three percent of the 1,189 women screened met
eligibility criteria and 67% of these women consented to participate in the study (N=498).
The primary reasons for declining to participate in the study included work or school
conflict, scheduling difficulties, child care issues and lack of interest. Participants were
included in the current analysis if they had cortisol and pregnancy anxiety data for at least
one time-point during the course of the study (N= 494).2 Forty six women were excluded
from the current sample due to missing demographic data or missing medical risk factor
variables.3 Therefore, 448 women comprised the final sample.
Table 1 shows demographic and medical risk data for this sample. Participants were 30
years of age on average. The sample was composed of 49% non-Hispanic white, 22%
Latina, 14% African American, and 9% Asian and was fairly socioeconomically diverse.
The majority of the women were married or cohabitating (88%). Slightly over half of the
women were carrying their first child (54%).
Measures
Maternal Cortisol—Saliva samples were scheduled for collection at least 1 hour after the
participant had eaten. Saliva samples were collected using a cotton gauze pad placed into a
syringe and then clarified by depressing the plunger. The samples were then stored at −20°C
until assayed. Mean collection time for the samples was 2:20 pm(SD = 1.92 hours). Thawed
samples were centrifuged at 3,000 rpm for 15 minutes before assay. All samples were
assayed in duplicate using a competitive solid-phase radioimmunoassay (Coat-A-Count;
Diagnostic Product Corp.). The test has a minimum detectable level of 0.02 μg/dl and the
intra- and inter-assay coefficients of the variance were 5.5% and 7.6%, respectively. Cortisol
data were log-transformed [ln(cortisol × 27.6)] and values outside ± 4 standard deviations
from the mean were removed from the current analyses (2 data points were removed from
T1, 1 from T2, 2 from T3 and 1 from T4).
Pregnancy Anxiety—Pregnancy anxiety was measured with a published 10-item scale at
each study visit (αT1 =.80, αT2 =.80 , αT3 =.82 , αT4 =.78 ) assessing the extent to which
women worried about their health during pregnancy, their baby's health, and their upcoming
labor and delivery (Rini, Dunkel Schetter, Wadhwa, & Sandman, 1999). Sample items
included: “I am fearful regarding the health of my baby” and “I am afraid that I will be
harmed during delivery.” Participants responded on a 4-point scale from 1(never or not at
all) to 4 (almost all of the time or very much). This instrument has been used in prior
pregnancy studies in English and Spanish speaking women with evidence for its reliability
and validity (Rini et al., 1999; Glynn, Dunkel Schetter, Hobel, & Sandman, 2008).
1Despite screening procedure efforts, it was revealed from information abstracted from medical records and self-report questionnaires
that a few (n=28) women smoked up to the first assessment (Time 1). By the 2nd assessment (Time 2), no women reported any
smoking. Because they were already enrolled in the study and occasional smokers, these women were retained in the study. A dummy
coded variable was created, 1 (smoking) and 0 (no smoking) and entered into all analyses. The results remained unchanged and
smoking was not a significant predictor of initial cortisol levels or cortisol trajectories. This variable was, therefore, not reported in the
analyses.
2Three participants were removed due to lack of cortisol data. One participant was removed due to lack of pregnancy anxiety data.
3Women not included in the final sample were not significantly different from women who were included in the final sample on any
study variables (all p's >.10).
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Pregnancy anxiety scores were quite stable over the course of pregnancy in this study (r's = .
65-.80)
Perceived Stress—Perceived stress was measured with a modified 12-item version of the
Perceived Stress Scale (PSS: Cohen, Kamarck & Mermelstein, 1983) at each visit except for
Time 2 (24-26 weeks) (αT1 =.91, αT3 =.93, αT4 =.93). This scale assessed how often
participants felt stressed, upset, overwhelmed by daily hassles, or unable to cope with
changes or challenges in the last 7 days. Sample items included: “How often have you felt
that you were on top of things?” (reverse coded) and “How often have you found that you
could not cope with all the things you had to do?” Participants responded on a 5-point scale
from 1 (never) to 5 (almost always). Perceived stress scores were moderately to strongly
correlated across visits (r’s = .51-.63)
State Anxiety—State anxiety was measured with a 10-item brief version of the state
subscale of the State Trait Anxiety Inventory (STAI: Spielberger, Gorsuch, Lushene, Vagg
& Jacobs,1983) assessing symptoms of anxiety over the past few days at each visit (αT1 =.
89, αT2 =.90, αT3 =.91, αT4 =.91). Sample items included “I am worried” and “I feel at
ease” (reverse coded). Participants responded on a 4-point scale from 1 (not at all) to 4 (very
much). State anxiety scores were strongly correlated across visits (r's = .60-.63).
Medical Risk Variables—Three medical or obstetric risk factors were created from
information abstracted from medical charts by summing the total number of risks for (1)
general health (e.g., diabetes, pulmonary disease), (2) baseline and historical medical factors
that pose risk in pregnancy (e.g., pre-pregnancy weight under 100 lbs, pelvic inflammatory
disease, previous myomectomy, previous abortion) and, (3) risk factors in the index
pregnancy (e.g. anemia, threatened abortion, bacterial vaginosis, asthma, vaginal bleeding,
high blood pressure). These medical risk factors were based on known risks of preterm birth
and other adverse pregnancy outcomes. The number of risk factors ranged from 0 to 7 with
means close to 1 in each category (see Table 1).
Sociodemographics—Demographic variables including age, self-identified ethnicity,
education, income and parity were measured at the Time 1 visit (see Table 1).
Statistical Analyses
Multilevel modeling (MLM), using HLM 7 software (Raudenbush et al., 2011), was used to
explore the effects of pregnancy anxiety on initial levels of maternal cortisol at 19 weeks
and trajectories of maternal cortisol. MLM treats the data in a hierarchical manner with
observations nested within persons and it accounts for both between-person variation
(between-person differences) and within-person variation (within-person changes).
Time-invariant predictors, those measured only once, were centered so that 0 was a
meaningful value (e.g., the average age at the initial assessment, no obstetric or medical risk
factors). The primary time-varying predictors, those measured multiple times during
pregnancy (pregnancy anxiety, state anxiety and perceived stress) were parameterized as
two variables to represent between-person differences and within-person variation (Hoffman
& Stawski, 2009). These variables were parametertized in two different ways. In one set of
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analyses, the between-person variables reflected the means of pregnancy anxiety, perceived
stress and state anxiety for each woman averaged across all four assessments. These
variables were centered so that 0 was the sample mean. The within-person variables had
occasion-specific values at each time point that reflected deviance from the woman's mean
on that occasion. For example, if a woman's mean level of pregnancy anxiety was 2 and her
level of pregnancy anxiety at Time 4 was 3, then her within-person value of pregnancy
anxiety at Time 4 would be 1. In another analysis, between-person differences in pregnancy
anxiety reflected differences in initial or baseline levels of pregnancy anxiety at 19 weeks of
gestation. Within-person variation reflected deviations or changes over time from the
baseline assessment (Berg et al., 2009). Weeks of gestation, the measure of time, was
centered at 19 weeks. Cortisol collection time was a covariate, so it was grand-mean
centered. Missing data was accommodated using maximum likelihood estimation. Two-
hundred and seventy-two women had complete data, 114 were missing complete data from
one assessment, 37 from two assessments and 25 had complete data for only one
assessment.
We estimated a series of nested models using maximum likelihood estimation for fixed
effects and restricted maximum likelihood for random effects. First, we estimated an
unconditional means model to determine the amount of variation in cortisol due to between-
person differences and within-person changes or variation over the course of pregnancy.
Then we estimated an unconditional growth model with the addition of weeks of gestation to
estimate initial levels of cortisol and change in cortisol over gestation. Sample collection
time was included in all models. To insure that any associations between pregnancy anxiety
and cortisol were not due to actual medical risk or demographic factors we first assessed if
any of these variables were independently associated with cortisol. Only significant potential
third variables (covariates) were included in the primary analyses. We then ran models with
only the between-person and within-person pregnancy anxiety predictors followed by a
model that included state anxiety, perceived stress and any significant demographic or
medical risk covariates.
Results
Descriptive statistics for the primary variables illustrate the predicted rise in maternal
cortisol over gestation (see Table 2). Bivariate correlations among the independent variables
indicated that perceived stress and state anxiety were highly correlated, whereas pregnancy
anxiety was only moderately correlated with each of these variables (see Table 3).
Partial correlations adjusted for cortisol collection time indicated that pregnancy anxiety at
Time 1, Time 2 and Time 3 were significantly correlated with maternal cortisol levels at
Time 3 (see Table 4). Based on these results, we regressed cortisol at Time 3 over all three
respective pregnancy anxiety measurements adjusting for sample collection time in order to
test whether pregnancy anxiety at a particular time period in pregnancy independently
predicted cortisol levels at Time 3. Results indicated that no single time point was
independently associated with cortisol at Time 3 (all p's >.10).
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Maternal Cortisol Trajectories
Consistent with the general increase in cortisol over gestation, the unconditional means
model indicated that 78% of the total variation in cortisol was attributable to within-person
variation and 22% of the total variation in cortisol was attributable to differences between
women (ICC = .22). The unconditional growth model indicated that on average there was a
significant increase in cortisol over the course of pregnancy (γ = .034, SE=.002, p < .001).
The correlation between initial status and rate of change (r = −.93) showed that higher
cortisol levels at the initial assessment were associated with a decreased rate of change. The
addition of the quadratic rate of change term was not significant, nor did its addition
significantly improve model fit.
Demographic variables (age, level of education, self-reported income and self-identified
ethnicity/race), parity and the medical risk indices were added into the model individually.
Race/ethnicity was coded white (0) or non-white (1) in order to retain the largest sample and
because race/ethnicity was not the main focus of these analyses. Neither demographic
variables, medical risk indices nor parity were associated with either initial cortisol levels or
cortisol trajectories (p's > .10). Therefore, we did not adjust for any of these variables in the
primary analyses.4
Primary Analyses on Pregnancy Anxiety and Maternal Cortisol
First, we tested a model that included both mean levels of pregnancy anxiety averaged
across all four assessments and within-person deviations from mean levels at each
assessment simultaneously. We examined the degree to which mean pregnancy anxiety
levels and being higher or (lower) on pregnancy anxiety relative to mean levels at each
assessment predicted cortisol. Mean levels of pregnancy anxiety (between-person
differences) were not associated with initial cortisol levels at 19 weeks (γ = −.060 SE=.063,
p =.34). However, as indicated by a significant between-person pregnancy anxiety by weeks
of gestation interaction (γ = .013 SE=.004, p =.002), higher mean levels of pregnancy
anxiety were associated with steeper increases cortisol trajectories over the course of
pregnancy. To further explore this interaction and to determine when in gestation differences
in cortisol levels emerged, we centered each week of gestation at 0 and tested the intercept
differences in pregnancy anxiety. Significant differences in cortisol levels (intercepts)
emerged beginning between 30 and 31 weeks of gestation (γ = 0.077, SE=.040, p =.052 and
γ = 0.090 SE=.040, p =.024, respectively) and persisted until the end of pregnancy (see
Figure 1). In contrast to predictions, within-person deviations from each woman's individual
mean level of pregnancy anxiety did not predict cortisol (γ = .048 SE=.050, p =.33). Thus,
being higher (or lower) than a woman's individual mean pregnancy anxiety level on each
measurement occasion was not associated with her cortisol levels.
In a second analysis, we tested a model that included both baseline levels of pregnancy
anxiety at 19 weeks of gestation and within-person changes from baseline levels at each
subsequent assessment (Berg et al., 2009).5 We examined the degree to which baseline
4Although medical risk was not a significant predictor of cortisol levels or trajectories in our preliminary analyses, we ran a model
that included the medical risk variables. Mean levels of pregnancy anxiety remained a significant predictor cortisol trajectories (γ = .
014 SE=.004, p =.002).
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pregnancy anxiety levels and increases or decreases from baseline levels predicted cortisol.
Results of this analysis were quite similar to the results of the previous analysis. Baseline
levels of pregnancy anxiety (between-person differences) were not associated with initial
cortisol levels at 19 weeks (γ = −0.016 SE=.052, p = .76). However, as indicated by a
significant between-person pregnancy anxiety by weeks of gestation interaction (γ = 0.008
SE=.003, p = .016), higher baseline levels of pregnancy anxiety were associated with steeper
increases in cortisol trajectories. Changes (increases or decreases) in pregnancy anxiety from
baseline were not associated with cortisol (γ = 0.070 SE=.046, p = .13).
Finally, to determine if the effect of mean pregnancy anxiety on cortisol was being driven by
pregnancy anxiety at any particular measurement occasion, we tested three additional
models to determine if pregnancy anxiety at each remaining assessment (Time 2, Time 3,
Time 4) was associated with cortisol trajectories. The results of these analyses revealed that
pregnancy anxiety measured at Time 2 (γ = .012 SE=.003, p =.002, n = 398), Time 3 (γ = .
010 SE=.003, p =.009, n = 401), and Time 4 (γ = .012 SE=.004, p =.006, n = 344) all
predicted cortisol trajectories.6
Pregnancy Anxiety as an Independent Predictor of Maternal Cortisol
To test whether mean levels of pregnancy anxiety remained a significant predictor of
cortisol trajectories after adjusting for other measures of general distress, state anxiety and
perceived stress were each added to the model individually. The results revealed that mean
levels of pregnancy anxiety remained a significant predictor of cortisol trajectories after
adjusting for both state anxiety (γ =.013, SE= .005, p =.009) and perceived stress (γ = .01
SE= .005, p=.027). Neither mean levels, nor deviations from mean levels of state anxiety or
perceived stress were significant predictors of cortisol trajectories in these models. When
state anxiety and perceived stress were entered into the model together, pregnancy anxiety
again remained a significant predictor of cortisol trajectories (see Table 5).
Discussion
In this study, pregnancy anxiety and maternal salivary cortisol levels were assessed in a
sample of 448 women on four occasions during pregnancy. Repeated assessments of both
pregnancy anxiety and cortisol permitted the use of multilevel modeling to test the extent to
which within-person changes and between-person differences in pregnancy anxiety
predicted prenatal cortisol trajectories. Results revealed that women with higher mean levels
of pregnancy anxiety over the course of the study exhibited steeper increases in cortisol
compared to women with lower mean levels. Furthermore, women who reported higher
mean pregnancy anxiety had significantly elevated cortisol levels beginning between 30 and
31 weeks of gestation and these elevations persisted for the rest of pregnancy. Of note,
pregnancy anxiety also remained an independent predictor of cortisol after adjusting for
state anxiety and perceived stress.
5The sample for this analysis was 445 women because 3 cases were missing pregnancy anxiety at Time 1.
6We note that each of these models includes a slightly different sample size due to differences in the number of cases with pregnancy
anxiety scores at each assessment. Results did not significantly change when using Empirical Bayes estimates of the intercepts
(pregnancy anxiety levels) at each assessment utilizing the entire sample of 448 women.
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This study is the first to demonstrate that mean levels of pregnancy anxiety from mid to late
pregnancy predict maternal cortisol trajectories across pregnancy and pinpoint when in
gestation (30-31 weeks) these trajectories diverge resulting in cortisol level differences.
Although we do not know why these trajectories diverge later rather than earlier in
pregnancy, the present findings support the premise that pregnancy anxiety plays a role in
modulating HPA activity in pregnant women. The results are consistent with previous
studies demonstrating positive associations between pregnancy anxiety and prenatal HPA
and placental activity (Mancuso et al., 2004; Obel et al., 2005).
By simultaneously taking into account both between- and within-person variation in
pregnancy anxiety, the present findings clarify which type of variation is predictive of
maternal cortisol. In doing so, the possibility of between- and within-person effects being
confounded is reduced. Mean levels of pregnancy anxiety and baseline levels of pregnancy
anxiety (between-person differences) predicted cortisol, whereas changes in pregnancy
anxiety relative to mean levels or baseline levels (within-person changes) did not predict
cortisol. Furthermore, regression analyses and additional multilevel modeling analyses
suggested that mean pregnancy anxiety was a consistent predictor of cortisol trajectories.
The regression analyses demonstrated that pregnancy anxiety measured at three occasions
during pregnancy (T1: 18-20 weeks, T2: 24-26 weeks, and T3: 30-32 weeks) all predicted
maternal cortisol, but not independently of each other. The multilevel analyses demonstrated
that pregnancy anxiety at each time point predicted cortisol trajectories. Thus, the effect of
mean pregnancy anxiety was not being driven by pregnancy anxiety at any particular
measurement occasion.
Although a few prior studies have shown that distress measures averaged across pregnancy
are predictive of gestational length (Lobel, Dunkel Schetter, & Scrimshaw, 1992; Roesch et
al., 2004), the majority of studies show that pregnancy anxiety at specific times in gestation
or changes over time in pregnancy anxiety are predictive of birth and infant outcomes (e.g.,
Buitelaar et al., 2003; Buss et al., 2009; Mancuso et al., 2004). There are several potential
explanations for why changes in pregnancy anxiety were not predictive of cortisol in the
current study. First, some measures of pregnancy anxiety may be more sensitive to changes
in pregnancy anxiety. For example, Mancuso et al. (2004) found a timing effect of
pregnancy anxiety predicting HPA activity (pCRH) using a measure that assessed pregnancy
anxiety with an adjective checklist (e.g., worried, jittery) and a specified timeframe of the
past week. Second, although pregnancy anxiety measured in this study was relatively stable
from mid to late gestation, pregnancy anxiety decreased over gestation on average. Thus,
outcomes measured in other studies demonstrating timing effects such as infant development
may be more sensitive than cortisol to small changes in pregnancy anxiety assessed with this
measure. Additionally, the present study only assessed changes in pregnancy anxiety from
mid to late gestation and potentially predictive changes from early in gestation were not
included. Finally, because significant changes in cortisol occurred early in the third
trimester, it is possible that there is an accumulation effect of pregnancy anxiety on cortisol
levels.
It is difficult to directly compare these results to previous studies because of the use of
different measures of pregnancy anxiety, different assessments of cortisol (cortisol
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awakening response (CAR), single assessments, early morning and evening cortisol) and
different cortisol collection methods (saliva, plasma). In this study, cortisol trajectories
diverged between 30 to 31 weeks of gestation suggesting why some cross-sectional studies
measuring cortisol and pregnancy anxiety earlier in pregnancy did not find an association
(e.g., Harville et al., 2009; Skikkema et al., 2001). However, one study did examine cross-
sectional associations later in pregnancy with the same pregnancy measure in the present
study and still found no association (Davis & Sandman, 2010), but this study had a relatively
smaller sample of women.
Our findings underscore the necessity of longitudinal designs to better understand how
different types of prenatal distress are associated with maternal physiology and birth and
infant outcomes. The use of slightly different conceptualizations and measures of pregnancy
anxiety may result in inconsistent results with respect to effects on maternal physiology and
birth and infant outcomes. Pregnancy anxiety as now conceptualized is a risk factor that is
related to yet distinct from general distress, state and trait anxiety. Ongoing research is
examining the properties and correlates of pregnancy anxiety (Dunkel Schetter & Glynn,
2011; Guardino & Dunkel Schetter, in press). Elucidating when and how pregnancy anxiety
affects these outcomes is critical for the development of theory and ultimately intervention.
In addition to implications for birth outcomes such as PTB (Dunkel Schetter, 2011), these
results are relevant to understanding fetal and infant development because fetal exposure to
excessive maternal cortisol has been shown to affect fetal HPA axis development and
resultant infant stress regulation (Sandman et al., 2012). Even small changes in maternal
cortisol may have a meaningful effect on fetal concentrations of cortisol. Fetal cortisol
concentrations are much lower than maternal cortisol concentrations, so the addition of any
maternal cortisol crossing the placental barrier can greatly alter fetal cortisol concentrations.
For this reason, maternal cortisol has been thought to have a large impact (Gitau et al.,
1998). Furthermore, it appears that maternal cortisol may influence fetal cortisol
concentrations to an even greater extent when a woman is highly anxious during pregnancy
through the down-regulation of the enzyme 11 β-HSD2 (Glover et al, 2009; O'Donnell et al.,
2012). It is possible that women who are high in pregnancy anxiety not only produce more
cortisol, but these increased levels may also affect the fetus to a greater extent because more
cortisol is allowed to pass through the placental barrier.
A strength of this study was the careful characterization of medical and obstetric risks. An
alternative explanation for our findings is the women with greater medical and obstetric risk
factors may have higher pregnancy anxiety creating a spurious association between
pregnancy anxiety and maternal cortisol. However, pregnancy anxiety was not associated
with obstetric risk factors in prior pregnancies and was only marginally associated with
obstetric risk factors in the current pregnancy. Moreover, adjusting for medical and obstetric
risk factors did not alter the reported results. Therefore, it is unlikely that medical and
obstetric risk factors explain the association of pregnancy anxiety and cortisol in this
sample. Continuing to explore these associations is important for future research.
Although the assessment of maternal cortisol at multiple time points during pregnancy is a
strength of the study design, the collection of a single assessment at each time point is a
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potential limitation. To help mitigate this limitation, we carefully recorded the time of day
each sample was collected and statistical adjusted for the sample collection time in all
analyses. Nevertheless, future research should examine changes in diurnal cortisol over
pregnancy and consider how diurnal cortisol slopes might change as a function pregnancy
anxiety. For example, in one study, flatter diurnal cortisol slopes were associated with
higher trait anxiety late in pregnancy (Kivlighan et al., 2008), but changes in diurnal slopes
over pregnancy were not assessed.
Conclusion
Pregnancy anxiety is a relatively new concept and a seemingly powerful prenatal risk factor.
Although strong evidence from animal models identifies cortisol as a key physiological
mechanism explaining the effects of prenatal distress on birth and infant outcomes, there is
not sufficient evidence in human studies. These results provide initial evidence for the
association between pregnancy anxiety and maternal cortisol in humans. They demonstrated
that higher mean levels of pregnancy anxiety from mid to late pregnancy were associated
with steeper increases in maternal cortisol compared to lower levels and identified
differences in cortisol levels beginning early in the third trimester. This association is a
critical first link in understanding the physiological mechanisms through which pregnancy
anxiety may exert its effects on birth and infant outcomes. Finally, these findings further
highlight the need to understand how pregnancy anxiety affects maternal physiology -- not
just whether or not it does.
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Highlights
• We examine the association between pregnancy anxiety and maternal prenatal
cortisol
• Higher pregnancy anxiety predicted steeper increases in cortisol trajectories
relative to lower
• Cortisol trajectories significantly diverged between 30 and 31 weeks gestation
• Results remained significant adjusting for state anxiety and perceived stress
• Pregnancy anxiety may be linked to birth and infant outcomes via prenatal
cortisol
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Figure 1.
Cortisol trajectories over gestation by between-person pregnancy anxiety.
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Table 1
Sample socio-demographics and medical history.
Variables N (%)
Age at Time 1 M=30 (SD=5.20, range= 18-43)
Ethnicity
    Non-Hispanic White 221 (49.3%)
    Latina 99 (22.1%)
    African-American 61 (13.6%)
    Asian 40 (8.9%)
    Multi-ethnic/Other 27 (6.9%)
Income
    < $10,000 20 (4.5%)
    $10,001 - $30,000 67 (15.0%)
    $30,001 - $50,000 87 (19.4%)
    $50,001 - $70,000 91 (20.3%)
    $70,001 - $90,000 60 (13.4%)
    > $90,000 123 (27.5%)
Education
    High School or less 70 (15.6%)
    Some college 175 (39.1%)
    Bachelor's degree 123 (27.5%)
    Graduate degree 80 (17.9%)
    Married or Cohabitating 396 (88.4%)
Parity
    Nulliparous 242 (54.0%)
    Multiparous 206 (46.0%)
Current Obstetric Risk Factors M=1.15 (SD=1.40, range = 0-7)
Historical Obstetric Risk Factors M= 0.75 (SD=0.99, range = 0-6)
Medical History Risk Factors M=1.20 (SD=1.14, range = 0-5)
Note:N=448
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Table 2
Descriptive statistics for primary variables at each assessment.
Gestational Age 18-20 weeks (Time 1) 24-26 weeks (Time 2) 30-32 weeks (Time 3) 36 -38 weeks (Time 4)
Pregnancy Anxiety
    Mean (SD) 1.91 (0.53) 1.79 (0.48) 1.78 (0.48) 1.73 (0.44)
        N 445 398 401 344
State Anxiety
    Mean (SD) 2.04 (0.60) 1.96 (0.61) 1.99 (0.65) 2.06 (0.63)
        N 442 400 407 333
Perceived Stress
    Mean (SD) 2.26 (0.64) [Not assessed] 2.27 (0.70) 2.27 (0.71)
        N 444 401 344
Salivary Cortisol1
    Mean (SD) 0.22 (0.18) 0.30 (0.23) .34 (0.24) .40 (0.22)
        N 438 414 401 341
1
Raw values, μg/dl.
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Table 4
Partial correlations between pregnancy anxiety and Cortisol adjusting for time of day of cortisol assessments.
Cortisol 18-20 weeks Cortisol 24-26 weeks Cortisol 30-32 weeks Cortisol 36 -38 weeks
Pregnancy Anxiety T1 .00 −.03
.11* .05
    N 436 411 397 339
Pregnancy Anxiety T2 −.04
.16** .06
    N 389 372 313
Pregnancy Anxiety T3
.17** .08
    N 388 330
Pregnancy Anxiety T4 .06
    N 338
Note:
different sample sizes reflect different numbers of cases of both pregnancy anxiety and cortisol at each measurement occasion
**p<.01
*p<.05
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Table 5
Pregnancy anxiety predicting cortisol trajectories adjusting for state anxiety and perceived stress
Parameters Estimate SE p - value
Intercept (initial status at 19 weeks) 1.647 .03 <.001
    Between-Person (BP) Pregnancy Anxiety −0.021 .08 .79
    Between-Person (BP) State Anxiety 0.032 .09 .73
    Between-Person (BP) Perceived Stress −0.047 .07 .52
Linear slope (gestational age) 0.036 .00 <.001
    BP Pregnancy Anxiety 0.011 .00 .032
    BP State Anxiety −0.002 .01 .73
    BP Perceived Stress 0.003 .01 .55
Time collected −.097 .01 <.001
Within-Person Pregnancy Anxiety 0.096 .06 .094
Within-Person State Anxiety −0.053 .04 .21
Within-Person Perceived Stress 0.038 .04 .35
Variances/Covariances Estimate SE
    Intercept variance .148 .02
    Covariance −.005 .00
    Slope variance .000 .00
Note: N = 447 in this model because of one case with missing state anxiety. Between- person variables represent means across all 4 assessments.
Within-person variables represent the deviation from each woman's individual mean at each assessment.
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